PM Modi reviews availability of oxygen and medicines

A high-level meeting was chaired by Prime Minister Narendra Modi to review the availability and supply of oxygen and medicines as Covid-19 cases continue to surge.

New Delhi: Prime Minister Narendra Modi on Wednesday chaired a high-level meeting to review the availability and supply of oxygen and medicines in the wake of the surge of COVID-19 cases in the country.

He was briefed that the government is actively monitoring the supply of drugs being used in the management of COVID-19 as well as 'Mucormycosis'.

Read:Delhi left with 4,35,070 COVID vaccine doses for 18-44 age group

A PMO release said the ministers updated the Prime Minister that they are in regular touch with the manufacturers to enhance production and extend all kinds of help needed. He was also informed about the current production and stock of Active Pharmaceutical Ingredients (APIs) for each such drug.

The meeting was briefed that states are being provided medicines in good quantities. The Prime Minister was also informed that the production of all drugs including Remdesivir has been ramped up significantly in the last few weeks.

He said that India has a very vibrant pharma sector and the government's continued close coordination with them will ensure the proper availability of all medicines.

He also took stock of the situation on oxygen availability and supply in the country. It was discussed that the supply of oxygen is now more than three times the supply during the peak of the first wave.

Read:Delhi court grants bail to 4 accused in oxygen concentrators hoarding case

He was briefed about the operations of oxygen rail and sorties by IAF planes. The Prime Minister was also informed about the status of procurement of oxygen concentrators, oxygen cylinders as well as the status of PSA plants being installed across the country.

He remarked that states should be asked to operationalize ventilators in a time-bound manner and resolve technical and training issues with the help of the manufacturers.

(ANI)